Completed

Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

755nm Alexandrite Laser

Device
Who is being recruted

Fibrosis+1

+ Pathologic Processes

+ Pathological Conditions, Signs and Symptoms

From 18 to 85 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: June 2012
See protocol details

Summary

Principal SponsorCynosure, Inc.
Last updated: January 14, 2021
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2012

Actual date on which the first participant was enrolled.

Evaluate the safety and efficacy of removing unwanted scars using a 755nm Alexandrite laser.

NCT01811030
Principal SponsorCynosure, Inc.
Last updated: January 14, 2021
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

33 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

FibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsCicatrix

Criteria

4 inclusion criteria required to participate
Has unwanted scars (including atrophic, hypertrophic, hyper or hypo pigmented, erythematous )and wishes to undergo laser treatments to remove or improve them
Is a healthy male or female between 18 and 85 years old
Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits
Is willing to consent to participate in the study
10 exclusion criteria prevent from participating
Has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications
Has a history of keloid scarring
Has a history of squamous cell carcinoma or melanoma
Has active localized or systemic infection
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
755nm Alexandrite Laser

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Laser & Skin Surgery Center of New York

New York, United StatesOpen Laser & Skin Surgery Center of New York in Google Maps
CompletedOne Study Center